CPC Advisors LLC Sells 18,385 Shares of CME Group Inc. $CME

CPC Advisors LLC trimmed its position in CME Group Inc. (NASDAQ:CME) by 67.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,708 shares of the financial services provider’s stock after selling 18,385 shares during the quarter. CPC Advisors LLC’s holdings in CME Group were worth $2,572,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the company. Vanguard Group Inc. grew its stake in CME Group by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after buying an additional 588,509 shares during the last quarter. State Street Corp lifted its position in CME Group by 0.4% during the 4th quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock worth $4,408,747,000 after acquiring an additional 56,725 shares during the last quarter. Norges Bank acquired a new position in CME Group during the 4th quarter worth $1,523,241,000. Bank of New York Mellon Corp lifted its position in CME Group by 2.8% during the 4th quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after acquiring an additional 134,242 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its holdings in CME Group by 2.8% during the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock valued at $1,300,450,000 after acquiring an additional 130,848 shares during the period. 87.75% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CME. TD Cowen lowered their price target on CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price for the company in a research note on Thursday. Argus restated a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. Finally, The Goldman Sachs Group lowered their target price on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a report on Thursday, April 23rd. Twelve research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group currently has a consensus rating of “Moderate Buy” and an average target price of $305.18.

Insider Transactions at CME Group

In related news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by company insiders.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
• Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
• Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
• Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
• Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

CME Group Price Performance

Shares of CME Group stock opened at $246.38 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $244.56 and a fifty-two week high of $329.16. The firm has a fifty day moving average price of $279.61 and a two-hundred day moving average price of $287.27. The company has a market cap of $89.28 billion, a PE ratio of 21.02, a price-to-earnings-growth ratio of 2.75 and a beta of 0.21.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period last year, the business posted $2.80 EPS. The business’s quarterly revenue was up 14.5% on a year-over-year basis. Analysts expect that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. CME Group’s dividend payout ratio (DPR) is 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.